CAPRELSA Co-Pay Assistance Program
Savings card from Sanofi
Caprelsa’s maker has a savings program. Its page doesn’t list a dollar amount.
From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.
Generic name: vandetanib
Used for: Medullary thyroid cancer
Ask for the cash price
Caprelsa
We didn’t find one.
Free from the maker, if you qualify CAPRELSA Patient Assistance Program. Or call 1-800-367-4999.
See if you qualifyDetails for each option
Savings card from Sanofi
Caprelsa’s maker has a savings program. Its page doesn’t list a dollar amount.
From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.
There isn’t one. An authorized generic is Caprelsa itself, from the same company, sold without the brand name, and usually for less. For now Caprelsa is the only choice; its maker’s savings card can lower what you pay.
We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.
CAPRELSA is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
Use CAPRELSA in patients with indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of CAPRELSA.
Source: the FDA label for Caprelsa (Genzyme Corporation), April 23, 2026. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/caprelsa/